GlaxoSmithKline wish to inform you of their intended withdrawal of Agenerase Oral Solution from the Irish Market from February 2008. Stock will continue to be available until 28th February 2008. The therapeutic alternative to Agenerase Oral Solution will continue to be marketed. This is: Telzir Oral Suspension 225ml. Full prescribing information available from www.medicines.ie This [...]

Janssen-Cilag Ltd. wish to announce that Eprex (epoetin alfa) 40,000 IU/ml solution for injection in 1ml vials are no longer marketed in both the UK and Ireland and currently have no stock left in supply. Eprex 40,000 IU/ml vial were indicated for the treatment of anaemia and reduction of transfusion requirements in adults patients. Eprex [...]

As part of a regular review of products in its pharmaceutical portfolio, Roche Products (Ireland) Ltd wish to inform you of the discontinuation of one of its products, Fansidar 500mg/25mg tablets (pack of 3). This decision is based on the fact that the product has been superseded by the availability of enhanced alternative treatments that [...]

The majority of withdrawals have been due to commercial rationalisation decisions. Products highlighted in bold apply to the current month. Benoral Benph Bipreterax Cardene Cefrom Coversyl Plus Deponit Dicynene Femodene Flucandid Intal Kinidin Durules Largactil Liquivisc MXL Melleril Migranat Myocrisin Nuvelle Oestrogel Orudis Piportil Premdoc Preterax Psorimed Quinapro Rimactane Rimactizid Rynacrom Sectral Surgam SA Sustanon [...]